Search results
Showing 5491 to 5505 of 8221 results
Recommendation ID NG106/5 Question Risk tools for predicting non-sudden death in heart failure:- What is the most accurate prognostic risk
Recommendation ID NG107/4 Question Frequency of review:- What is the most clinical and cost-effective frequency of review for people on
Recommendation ID NG101/7 Question Strategies to reduce arm and shoulder problems- What is the most effective and cost-effective way of
Recommendation ID NG235/2 Question What is the most effective dosage at which oxytocin should be recommenced once stopped in labour because
Recommendation ID NG198/2 Question Treatment options for people with polycystic ovary syndrome: What is the most effective first-line treatment
Recommendation ID CG155/6 Question What is the most effective management strategy for preventing the development of excessive weight gain
Recommendation ID NG215/08 Question Cognitive behavioural therapy (CBT) to support withdrawal from benzodiazepines: What is the most effective
Recommendation ID NG98/1 Question Idiopathic sudden sensorineural hearing loss:- What is the most effective route of administration of
Recommendation ID NG194/2 Question Timing of first health visitor visit: What is the most effective timing of the first postnatal contact
Postpartum haemorrhage: What is the most effective treatment for primary postpartum haemorrhage?
Recommendation ID CG190/05 Question Postpartum haemorrhage: What is the most effective treatment for primary postpartum haemorrhage?
Recommendation ID NG191/3 Question What is the effectiveness and safety of a treatment dose with a low molecular weight heparin (LMWHs)
Recommendation ID NG191/2 Question What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis
Recommendation ID NG191/15 Question What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2
Recommendation ID NG191/1 Question What is the effectiveness and safety of standard-dose compared with intermediate-dose pharmacological
Recommendation ID NG108/3 Question Advocacy and support for decision-making:- What is the effectiveness, cost effectiveness and acceptability